过去一年中添加的文章，按日期排序
Papillary thyroid carcinoma tall cell subtype (PTC‐TC) and high‐grade differentiated thyroid carcinoma tall cell phenotype (HGDTC‐TC) have different clinical …
R Ghossein, N Katabi, S Dogan, AR Shaha… - …, 2024 - Wiley Online Library
82 天前 - … importance of tumour necrosis and high mitotic count for accurate diagnosis and
prognosis of differentiated thyroid … BRAF V600E mutation status was obtained from the charts of …
prognosis of differentiated thyroid … BRAF V600E mutation status was obtained from the charts of …
Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend Regarding the Latest WHO Classification
T Chiba - Biomedicines, 2024 - mdpi.com
85 天前 - … (FTC) and papillary thyroid carcinoma (PTC) have specific … In PDTC and DHGTC,
RAS and BRAF mutations are … the prognostic importance of the co-existence of BRAF p.…
RAS and BRAF mutations are … the prognostic importance of the co-existence of BRAF p.…
Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend the Latest WHO Classification
T Chiba - 2024 - preprints.org
109 天前 - … (FTC) and papillary thyroid carcinoma (PTC) have specific … In PDTC and DHGTC,
RAS and BRAF mutations are detected at … Prognostic significance of diffuse sclerosing variant …
RAS and BRAF mutations are detected at … Prognostic significance of diffuse sclerosing variant …
Tyrosine kinase inhibitors for radioiodine refractory differentiated thyroid cancer: A systematic review and meta‐analysis
J Yu, Z Liu, Y Su, X Peng, Y Xie - Clinical Endocrinology, 2024 - Wiley Online Library
122 天前 - … Background: The poor overall prognosis of radioiodine refractory thyroid cancer is
an … distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of …
an … distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of …
[HTML][HTML] Pediatric Differentiated Thyroid Cancers
S Satapathy, C Bal - Journal of Head & Neck Physicians and …, 2024 - journals.lww.com
166 天前 - … The importance of genomic analysis for indeterminate … oncogene and less common
BRAF mutations, which are … -positive lung disease signifies better prognosis with more …
BRAF mutations, which are … -positive lung disease signifies better prognosis with more …
Matrix Metalloproteinase 9/microRNA-145 Ratio: Bridging Genomic and Immunological Variabilities in Thyroid Cancer
EA Toraih, MH Hussein, E Al Ageeli, M Ellaban… - Biomedicines, 2023 - mdpi.com
227 天前 - … In stratified analysis considering both BRAF mutation status and Hashimoto thyroiditis,
Table 4 elucidates the prognostic utility of the MMP9/miR-145 ratio across critical clinical …
Table 4 elucidates the prognostic utility of the MMP9/miR-145 ratio across critical clinical …
[PDF][PDF] Encorafenib and binimetinib as a new regimen for BRAF mutant non-small cell lung cancer
T Goto - AME Clinical Trials Review, 2023 - researchgate.net
227 天前 - … years, the prognosis of non-small cell lung cancer (NSCLC) … for clinical use in the
BRAFV600Emutant NSCLC patients. … High prevalence of BRAF mutations in thyroid cancer: …
BRAFV600Emutant NSCLC patients. … High prevalence of BRAF mutations in thyroid cancer: …
The Uncommon Cancer: Thyroid Carcinoma.
S Jackson - Oncology Nursing News, 2023 - go.gale.com
242 天前 - … At this time, they have shown use in low-risk thyroid carcinoma. This treatment
enhances uptake of radioactive iodine within the tissue of tumors, which assists in minimizing …
enhances uptake of radioactive iodine within the tissue of tumors, which assists in minimizing …
Update on molecular diagnostics in thyroid pathology: a review
B Alzumaili, PM Sadow - Genes, 2023 - mdpi.com
359 天前 - … both diagnostic and prognostic purposes, and its use has … molecular landscape of
papillary thyroid carcinoma (PTC) … not neatly attributed to the BRAF V600E -like or RAS-like …
papillary thyroid carcinoma (PTC) … not neatly attributed to the BRAF V600E -like or RAS-like …